FOXD2 and breast cancer: FOXD2-AS1 promotes breast cancer cell proliferation, invasion, migration, and drug resistance by positively regulating the PI3K/AKT signaling pathway, inhibits apoptosis, and accelerates breast cancer progression (Nong et al., 2021).